Monogram Orthopaedics, Inc.
MGRM · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 27% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -4,618% | – | -1,584.7% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | -3,765.8% | – | -1,880.6% |
| EPS Diluted | -0.5 | -0.61 | -0.47 | -0.4 |
| % Growth | 18% | -29.8% | -17.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |